Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-01-06

Clinical Trial Update: Evaluation and Standardization of Ginseng and it's Components for Blood Pressure Regulation [Phase 2]

View source ↗

Summary

Phase 2 trial update describing the evaluation and standardization of ginseng and its components for regulating blood pressure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ginseng (Panax ginseng)

Snippet

Sponsor: Unity Health Toronto | Conditions: Hypertension, Blood Pressure | Phase 2 | Status: COMPLETED